drugset / Trial / NCT04770701

Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes

NCT04770701 ↗

Phase 4 Withdrawn Trieu, Nguyen Thi, M.D.
NaSingle-groupOpen-labelTreatment

Summary

This is a plant-based medication used to increase the amount, protect, and reduce HIV's impact on T and B lymphocytes.

Timeline

Start
2020-09-20
Primary completion
2025-06-07
Completion
2026-06-06

Outcome

Outcome not reported

Stopped (Enrollment): “The study was withdrawn before enrollment due to administrative and board approval constraints.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ahah Unknown — —

Indications